Xenetic Biosciences Inc (XBIO): Shorts will lost multiple of the shorted...

Send PM Follow Ignore

Followers	4824
Posts	168889
Boards Moderated	1
Alias Born	02/21/2011

l2 hunter

Re: None

Tuesday, 06/26/2018 10:38:41 AM

Tuesday, June 26, 2018 10:38:41 AM

Shorts will lost multiple of the shorted money next days if XBIO jump up $30 area. think XBIO with enormus short quote. Not wonder if first smart guys cover before close today before tomorrow next 100% +× gain start

http://investorshub.advfn.com/boards/board.aspx?board_id=20962

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent XBIO News

Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 12:00:27 PM
Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results • ACCESS Newswire • 03/13/2026 12:00:00 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/12/2026 09:00:51 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2026 10:00:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 10:00:05 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 10:00:02 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/11/2025 10:01:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2025 10:00:43 PM
Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting • ACCESS Newswire • 12/11/2025 10:00:00 PM
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform • ACCESS Newswire • 11/19/2025 01:45:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 01:45:28 PM
Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 01:45:00 PM
Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 10/31/2025 08:30:06 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/31/2025 08:20:12 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/31/2025 08:10:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 12:48:56 PM
Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock • ACCESS Newswire • 10/10/2025 01:30:00 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/10/2025 01:28:19 PM
Top movers on Nasdaq and NYSE in Wednesday’s premarket session • IH Market News • 10/08/2025 03:55:52 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 12:00:36 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2025 09:00:57 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 12:27:52 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 09:00:16 PM
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 05/13/2025 08:30:32 PM
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/29/2025 09:00:10 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent XBIO News

More XBIO News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent XBIO News

Go Ad-Free